A Whiting School-led interinstitutional research team will develop a novel photoacoustic endoscope and fluorescent contrast agent to ensure total tumor…
FALLS CHURCH, Va.--(BUSINESS WIRE)--Retension Pharmaceuticals, Inc. is pleased to announce the successful closing of its Series A $10.4 million financing…
Natasha Sheybani, assistant professor of biomedical engineering at the University of Virginia School of Engineering, will collaborate with researchers at…
ROCKVILLE, Md.--(BUSINESS WIRE)--OS Therapies (NYSE American: OSTX) (“OS Therapies” or “the Company”), an ADC and Immunotherapy research and clinical-stage biopharmaceutical company,…